213OEfficacy and safety of apalutamide (APA) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC) from SPARTAN: Asian subpopulation. (25th November 2018) - Mainwaring, P; Small, E; Uemura, H; Lee, J Y; Pang, S-T; Marx, G; Kwon, T G; Satoh, T; Bhaumik, A; Cheng, S; Londhe, A; Lopez-Gitlitz, A; et al.